DK1611108T3 - Process for the preparation of telmisartan - Google Patents

Process for the preparation of telmisartan

Info

Publication number
DK1611108T3
DK1611108T3 DK04739071.1T DK04739071T DK1611108T3 DK 1611108 T3 DK1611108 T3 DK 1611108T3 DK 04739071 T DK04739071 T DK 04739071T DK 1611108 T3 DK1611108 T3 DK 1611108T3
Authority
DK
Denmark
Prior art keywords
telmisartan
preparation
Prior art date
Application number
DK04739071.1T
Other languages
Danish (da)
Inventor
Norbert Hauel
Rolf Dach
Helmut Heitger
Oliver Meyer
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33016100&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1611108(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK1611108T3 publication Critical patent/DK1611108T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
DK04739071.1T 2003-03-31 2004-03-26 Process for the preparation of telmisartan DK1611108T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10314702A DE10314702A1 (en) 2003-03-31 2003-03-31 Process for the preparation of telmisartan
PCT/EP2004/003217 WO2004087676A1 (en) 2003-03-31 2004-03-26 Method for the production of telmisartan

Publications (1)

Publication Number Publication Date
DK1611108T3 true DK1611108T3 (en) 2011-10-10

Family

ID=33016100

Family Applications (2)

Application Number Title Priority Date Filing Date
DK04739071.1T DK1611108T3 (en) 2003-03-31 2004-03-26 Process for the preparation of telmisartan
DK10192561.8T DK2322511T3 (en) 2003-03-31 2004-03-26 Process for Preparing Telmisartan

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK10192561.8T DK2322511T3 (en) 2003-03-31 2004-03-26 Process for Preparing Telmisartan

Country Status (26)

Country Link
US (2) US7193089B2 (en)
EP (2) EP1611108B1 (en)
JP (1) JP5160740B2 (en)
KR (1) KR101096499B1 (en)
CN (1) CN100418953C (en)
AR (2) AR043794A1 (en)
AT (1) ATE515500T1 (en)
AU (1) AU2004226239B2 (en)
BR (1) BRPI0408861A (en)
CA (1) CA2520714C (en)
CL (1) CL2004000687A1 (en)
CY (2) CY1112020T1 (en)
DE (1) DE10314702A1 (en)
DK (2) DK1611108T3 (en)
ES (2) ES2432647T3 (en)
IL (1) IL171145A (en)
MX (1) MXPA05009529A (en)
NZ (1) NZ543244A (en)
PE (1) PE20050390A1 (en)
PL (2) PL1611108T3 (en)
PT (2) PT1611108E (en)
RU (1) RU2430092C2 (en)
SI (2) SI1611108T1 (en)
TW (1) TWI335916B (en)
UY (1) UY28246A1 (en)
WO (1) WO2004087676A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10314702A1 (en) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for the preparation of telmisartan
GB2414019A (en) 2004-05-11 2005-11-16 Cipla Ltd One-step preparation of telmisartan by condensation and hydrolysis
DE102004045796A1 (en) * 2004-09-22 2006-03-23 Merck Patent Gmbh Medicaments containing carbonyl compounds and their use
KR20080112424A (en) * 2004-10-15 2008-12-24 테바 파마슈티컬 인더스트리즈 리미티드 Process for preparing telmisartan
US7943781B2 (en) 2004-10-18 2011-05-17 Dr. Reddy's Laboratories Limited Process for preparing telmisartan
WO2006103068A1 (en) * 2005-04-01 2006-10-05 Lek Pharmaceuticals D.D. A synthesis of 4-bromomethyl-2'-formylbiphenyl and 4-bromomethyl-2'- hydroxymethylbiphenyl and its use in preparation of angiotensin ii antagonists
ITMI20050801A1 (en) * 2005-05-03 2006-11-04 Dipharma Spa PROCEDURE FOR THE PREPARATION OF TELMISARTAN
WO2006136916A2 (en) * 2005-06-20 2006-12-28 Glenmark Pharmaceuticals Limited Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same
US20060264491A1 (en) * 2006-06-08 2006-11-23 Chemagis Ltd. Telmisartan production process
CN101172968B (en) * 2006-11-01 2010-05-12 浙江天宇药业有限公司 2-propyl-4 methyl-6-(tolimidazole-2group) benzoglioxaline salt and method for producing the same
EA200901619A1 (en) * 2007-07-03 2010-04-30 Крка, Товарна Здравил, Д. Д., Ново Место METHOD OF OBTAINING TELMISARTANA
CZ302272B6 (en) * 2007-07-09 2011-01-19 Zentiva, A. S. Process for preparing 4?-[[4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1yl]methyl]biphenyl-2-carboxylic acid (telmisartan)
WO2009116089A2 (en) * 2008-03-14 2009-09-24 Ipca Laboratories Limited Novel intermediates and method for synthesis of 4'-[(1,4'-dimethyl-2'-propyl-[2,6'- bi-1hbenzimidazol]-l-yl)methyl]-1,1-biphenyl]-2-carboxylic acid.
EP2103588A1 (en) * 2008-03-20 2009-09-23 Lek Pharmaceuticals D.D. 2'-Halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonists
EP2103609A1 (en) * 2008-03-20 2009-09-23 Lek Pharmaceuticals D.D. Catalyzed carbonylation in the synthesis of angiotensin ii antagonists
PL2279159T3 (en) * 2008-03-20 2014-05-30 Lek Pharmaceuticals 2'-halobiphenyl-4-yl intermediates in the synthesis of angiotensin ii antagonists
EP2123648A1 (en) 2008-05-20 2009-11-25 Chemo Ibérica, S.A. A process for the preparation of Telmisartan.
EP2149566A1 (en) 2008-07-15 2010-02-03 Chemo Ibérica, S.A. A process for the preparation of telmisartan
SI2443094T1 (en) 2009-06-19 2013-08-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of telmisartan
EP2277866A1 (en) * 2009-06-22 2011-01-26 Inke, S.A. Process for preparing telmisartan
EP2305650A1 (en) 2009-09-21 2011-04-06 Chemo Ibérica, S.A. Novel process for the preparation of telmisartan
EP2632438A1 (en) 2010-10-27 2013-09-04 KRKA, tovarna zdravil, d.d., Novo mesto Multilayer pharmaceutical composition comprising telmisartan and amlodipine
CN102267949A (en) * 2011-06-14 2011-12-07 张长利 New process for telmisartan preparation
WO2014027280A1 (en) 2012-08-14 2014-02-20 U Amarnath Amarnath One pot process for the preparation of telmisartan
CN103787982A (en) * 2012-10-31 2014-05-14 上海特化医药科技有限公司 Telmisartan preparation method and intermediate of telmisartan
CN104557724B (en) * 2014-11-17 2017-01-11 江苏中邦制药有限公司 Telmisartan amorphous crystal and preparation method thereof
CN105130905B (en) * 2015-09-17 2017-09-08 浙江金立源药业有限公司 A kind of synthetic method of Telmisartan
CN109912512B (en) * 2017-12-13 2023-05-30 上海科胜药物研发有限公司 New telmisartan impurity compound and preparation method and application thereof
CN112251770B (en) * 2020-10-14 2021-07-27 湖南大学 Novel electrochemical preparation method of antihypertensive drug telmisartan intermediate
CN113307775B (en) * 2021-04-16 2022-04-22 河北戴桥医药科技有限公司 Preparation method of telmisartan
WO2023204729A1 (en) * 2022-04-19 2023-10-26 Общество с ограниченной ответственностью "Гелеспон" Pharmaceutical compositions based on a novel substance of 4-[2-(1н-imidazol-4-yl)-ethylcarbamoyl]-butanoic acid and method for producing said substance

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4023369A1 (en) * 1990-07-23 1992-01-30 Thomae Gmbh Dr K New 1-bi:phenylyl:methyl benzimidazole derivs.
RU1836357C (en) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Benzimidazole derivatives, their isomers, mixtures of isomers, hydrates or their physiologically bearable salts possessing properties antagonistic to angiotenzine
SI9210098B (en) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoles, drugs with this compounds, and process for their preparation
US5591762A (en) * 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
DE4103492A1 (en) * 1991-02-06 1992-10-08 Thomae Gmbh Dr K New 1-(1,4-bi:phenyl-methyl) benzimidazole(s) as angiotensin II antagonists
US6358986B1 (en) * 1999-01-19 2002-03-19 Boehringer Ingelheim Pharma Kg Polymorphs of telmisartan
DE19901921C2 (en) * 1999-01-19 2001-01-04 Boehringer Ingelheim Pharma Polymorphs of telmisartan, process for their preparation and their use in the manufacture of a medicament
US6737432B2 (en) * 2001-10-31 2004-05-18 Boehringer Ingelheim Pharma Kg Crystalline form of telmisartan sodium
DE10314702A1 (en) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for the preparation of telmisartan

Also Published As

Publication number Publication date
JP2006521289A (en) 2006-09-21
CY1115156T1 (en) 2016-12-14
ES2432647T3 (en) 2013-12-04
DK2322511T3 (en) 2013-10-28
RU2430092C2 (en) 2011-09-27
ES2369081T3 (en) 2011-11-25
EP1611108B1 (en) 2011-07-06
UY28246A1 (en) 2004-11-08
KR20050118699A (en) 2005-12-19
AR043794A1 (en) 2005-08-10
EP2322511A1 (en) 2011-05-18
AU2004226239A1 (en) 2004-10-14
CA2520714A1 (en) 2004-10-14
JP5160740B2 (en) 2013-03-13
PT1611108E (en) 2011-09-01
PL2322511T3 (en) 2014-01-31
EP1611108A1 (en) 2006-01-04
US8993778B2 (en) 2015-03-31
US20040236113A1 (en) 2004-11-25
PT2322511E (en) 2013-08-29
CL2004000687A1 (en) 2005-02-04
ATE515500T1 (en) 2011-07-15
AU2004226239B2 (en) 2011-04-21
RU2005133479A (en) 2006-07-27
AR087209A2 (en) 2014-02-26
TWI335916B (en) 2011-01-11
SI2322511T1 (en) 2013-10-30
PL1611108T3 (en) 2011-12-30
US7193089B2 (en) 2007-03-20
BRPI0408861A (en) 2006-04-11
CN100418953C (en) 2008-09-17
NZ543244A (en) 2010-02-26
TW200504055A (en) 2005-02-01
SI1611108T1 (en) 2011-10-28
CY1112020T1 (en) 2015-11-04
PE20050390A1 (en) 2005-06-23
CA2520714C (en) 2012-05-15
CN1768044A (en) 2006-05-03
DE10314702A1 (en) 2004-10-21
US20130137878A1 (en) 2013-05-30
EP2322511B1 (en) 2013-07-31
KR101096499B1 (en) 2011-12-20
WO2004087676A1 (en) 2004-10-14
MXPA05009529A (en) 2005-10-19
IL171145A (en) 2010-12-30

Similar Documents

Publication Publication Date Title
DK1611108T3 (en) Process for the preparation of telmisartan
DK1828164T3 (en) Process for the preparation of N-phenylpyrazole-1-carboxamides
DK1778668T3 (en) Process for the preparation of dihydropteridione
DK1893586T3 (en) Process for the preparation of 1-alkyl-3-phenyluracils
CR8226A (en) PROCESS FOR THE PREPARATION OF 4-AMINO-3-QUINOLINCARBONITRILOS
DK1546122T3 (en) Process for the preparation of valsartan
DK1651622T3 (en) Process for the preparation of 2- (quinoxaline-5-ylsulfonylamino) benzamide compounds
DK1756049T3 (en) Process for Preparation of 1,4-Diphenylazetidinone Derivatives
NO20076030L (en) Process for the preparation of hydrochlorosilanes
DK1840125T3 (en) Intermediates for the preparation of dioxane-2-alkylcarbamates
DK1831223T3 (en) Process for the preparation of L-biopterin
DK1667967T3 (en) Process for the preparation of 2-oxo-1-pyrrolidine derivatives
DK1856035T3 (en) Process for the preparation of protection amidines
NO20044814L (en) Process for the preparation of combretastanines
DK1678135T3 (en) Process for the preparation of n-amino-substituted hetorocyclic compounds
IS7958A (en) Process for the preparation of methyl 2-diphenylmethylsulfinyl acetate
DK1572613T3 (en) Process for the preparation of benzophenones
DK1575941T3 (en) Process for Preparation of (S) -Pantoprazole
DK1912961T3 (en) Process for the preparation of bepromolin
DK1682541T3 (en) Process for the preparation of tiotropium salts
DK1931618T3 (en) Process for the preparation of anilines
DK1727792T3 (en) Process for the preparation of semicarbazones
DK1937662T3 (en) Process for the preparation of duloxetine
DK1660485T3 (en) Improved process for the preparation of alpha-polymorphic eletriptan hydrobromide
DK1511724T3 (en) Process for the preparation of thioalkylamine derivatives